NEW YORK, NY — As the month of October arrives, the global landscape is often awash in pink ribbons, a ubiquitous symbol of breast cancer awareness. However, for the tens of thousands of individuals living with metastatic breast cancer (MBC)—the most advanced and terminal stage of the disease—the standard narrative of "early detection" and "beating the odds" can feel alienating and incomplete.
On October 13, National Metastatic Breast Cancer Awareness Day, the nonprofit organization METAvivor is reclaiming the conversation. Through its monumental global campaign, #LightUpMBC, more than 325 landmarks across 20 countries, 195 cities, and all 50 U.S. states will illuminate in the colors of teal, green, and pink. This is more than a visual spectacle; it is a profound act of defiance against a disease that, while incurable, is in desperate need of a scientific breakthrough.
The Reality of the Stage 4 Crisis
To understand the urgency of #LightUpMBC, one must first confront the stark medical reality of metastatic breast cancer. Unlike early-stage breast cancer, which is often treated with the expectation of a cure, MBC occurs when cancer cells spread from the breast to distant organs—most commonly the bones, liver, lungs, or brain.
It is important to clarify a common misconception: MBC remains breast cancer regardless of where it resides in the body. While some patients are diagnosed at Stage 4 from their initial visit to the doctor, many others—a population often referred to as "de novo" patients—develop the disease years or even decades after completing what they believed to be successful treatment for earlier stages.
For these individuals, the "finish line" does not exist. Treatment is a continuous, lifelong marathon. Even when medical scans show "no evidence of disease," it does not equate to a cure. It simply means the disease is currently being suppressed. As cancer cells evolve and develop resistance to therapies, patients must frequently switch protocols, navigating a precarious cycle of toxicity, side effects, and hope.
According to national health data, an estimated 42,670 people in the United States are projected to die from breast cancer in 2026 alone—a staggering figure that equates to approximately 117 lives lost every single day. These are not just statistics; they are mothers, fathers, siblings, and friends.
A Chronology of the Movement
The journey of #LightUpMBC is a testament to the power of a single voice. The movement began as a grassroots endeavor fueled by grief and the desire for change.
- 2017: The movement took its first physical form when Portsmouth’s Memorial Bridge in New Hampshire became the first landmark to illuminate in teal, green, and pink, signaling the colors of the MBC awareness ribbon.
- The Inception: Founder Laura Inahara launched the campaign in honor of her best friend, Jessica Moore, who tragically lost her battle with MBC at the age of 36. Jessica’s singular wish was to see one local landmark lit to honor those fighting the disease.
- Global Expansion: What started as a local tribute rapidly evolved into a global phenomenon. Year after year, the number of participating structures grew, encompassing iconic sites such as New York’s One World Trade Center, Chicago’s Willis Tower, the majestic Niagara Falls, and international landmarks like the Ness Bridge in Scotland and the Mactan-Cebu Airport in the Philippines.
- 2026 and Beyond: Today, #LightUpMBC stands as the largest fundraiser for METAvivor, having successfully raised over $2.7 million to date for critical research. The movement has transitioned from a simple lighting event into a multifaceted media experience that integrates education, advocacy, and high-production musical performances.
Supporting Data: Why Research is the Only Answer
The core philosophy of METAvivor is simple yet radical: they are the only national organization in the United States that exclusively funds Stage 4 metastatic breast cancer research.
The organization operates under the belief that the current funding landscape for cancer research is skewed. While early detection is vital, the majority of breast cancer research funding is directed toward prevention and early-stage treatment. Consequently, those living with metastatic disease often find themselves with limited options when initial therapies fail.
METAvivor addresses this gap through a rigorous, two-tiered grant process. Every research project is vetted by a panel of scientific experts—to ensure medical validity—and a panel of patient advocates—to ensure that the research addresses the actual needs and quality-of-life concerns of those living with the disease. By funding projects that specifically target the mechanisms of metastasis, METAvivor aims to transform MBC from a terminal diagnosis into a chronic, manageable, and survivable condition.
Voices of the Frontline: Official Perspectives
The human element of this campaign is what drives its impact. Dr. Kelly Shanahan, Board President of METAvivor, has lived the reality of this diagnosis for 13 years—a timeline that defies initial medical expectations.
"When I was diagnosed with metastatic breast cancer in 2013, I certainly didn’t think I’d still be here 13 years later," Dr. Shanahan remarked. "My hope and the hope of so many others lies in research, and METAvivor-funded research is increasingly important these days. #LightUpMBC is the biggest contributor to this research, and is also a way to bring us together as a community."
Laura Inahara, reflecting on the growth of the project, noted the enduring legacy of her late friend. "Jessica hoped to illuminate one local landmark. Today, her legacy helps families around the world shine a light for the people they love, teaches patients with MBC how to advocate for themselves, and has now raised millions for critical research."
The #LightUpMBC Live Experience
This year, the centerpiece of the campaign is the #LightUpMBC Live broadcast, airing on October 13 at 8 p.m. ET / 5 p.m. PT. The program is designed to bridge the gap between clinical science and the lived experience of patients.
Hosted by Tami Eagle Bowling—a 11-year MBC survivor—and Broadway star Kara Lindsay, the event promises to be a powerful blend of advocacy and art. The broadcast will feature:
- Patient Stories: Raw, unfiltered accounts shared directly from the base of illuminated landmarks.
- Scientific Insight: Expert commentary on the latest breakthroughs and the future of treatment modalities.
- Musical Performances: A star-studded lineup including two-time Tony Award winner Victoria Clark, Tony nominee Dorian Harewood, actress Christina Bianco, singer-songwriter Cassandra Kubinski, and legendary voiceover artist Tony Daniels.
The broadcast will be available for free on the METAvivor YouTube channel, Facebook Live, and via the streaming platform LiveOne.
Implications: Changing the Future of Oncology
The implications of the #LightUpMBC movement extend far beyond the single evening of illumination. By raising both capital and awareness, the campaign is shifting the national conversation. It is forcing a public reckoning with the fact that "awareness" without "research funding" is insufficient.
As the campaign gains momentum, the pressure on the medical and pharmaceutical communities to prioritize Stage 4 research increases. Every dollar raised through this campaign is a direct investment in the possibility of a longer life for a patient who, until recently, had few options.
For the public, the call to action is clear. On October 13, citizens are encouraged to visit their local landmarks, document the displays of teal, green, and pink, and share them on social media using the hashtags #LightUpMBC and #METAvivor.
In a world where medical progress is often measured in decades, METAvivor is working to accelerate that timeline. By uniting the world under a canopy of light, they are ensuring that those living with metastatic breast cancer are seen, heard, and—most importantly—supported in their fight for a future.
To view a full list of participating landmarks, find streaming links for the live broadcast, or make a contribution to the research fund, visit www.lightupmbc.org. Every contribution, regardless of size, serves as a beacon of hope in the ongoing effort to turn the tide against terminal breast cancer.
About the Author
